Bigomics : Challenges and promises in large scale sequencing projects

Size: px
Start display at page:

Download "Bigomics : Challenges and promises in large scale sequencing projects"

Transcription

1 Bigomics : Challenges and promises in large scale sequencing projects Theodore M. Wong Ken Yocum MSST Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life, Oligator, Sentrix, GoldenGate, GoldenGate Indexing, DASL, BeadArray, Array of Arrays, Infinium, BeadXpress, VeraCode, IntelliHyb, iselect, CSPro, GenomeStudio, Genetic Energy, HiSeq, and HiScan are registered trademarks or trademarks of Illumina, Inc. All other brands and names contained herein are the property of their respective owners.

2 The promise of the Illumina $1000 genome! Less interesting: sequence populations to do anthropological studies! Much more interesting: sequence populations of cancer patients to discover the causes and cures for cancer 2

3 Curing cancer the grand challenge of genomics! Occurs in ~1.6 million new patients each year in the United States! Kills ~0.6 million patients each year! Affects ~13 million people in any given year! Caused by genetic mutations 3

4 The goal of genomic oncology Create a one million whole genome + phenotype record repository of cancer patient genomes, to facilitate research into the genetic causes of cancer and individualized treatments for cancer patients! Why the whole genome? May enable treatments based on a combination of mutated and non-mutated genes Enables reanalysis of newly identified functional regions (e.g., ENCODE project)! Why a million? Enables statistically valid discovery of cancer-causing mutations 4

5 Challenges facing genomic oncology today! Extracting useful, structured genome + phenotype (G+P) records from raw sequencer data and electronic health records! Getting consented records for a meaningful-size cohort of study participants! Protecting the privacy of G+P records for participants / patients 5

6 Genome sequencing in one slide Sample Sequencer Short reads Aligner Potential genomes AAGA ACTT ACTC CCGA CGAC CTCC AAGACTCCGACTGGGACTTT AAGACTGGGACTCCGAT AGATGGCCGAT 6

7 Phenotype extraction in one slide patient consent doctor Samples DNA-Normal DNA-Tumor RNA text narrative EHR Clinical data Sequence 30x - fastq.gz - 80GB 90x - fastq.gz - 238GB fast.gz -? GO(OCR(text)) GO(EHR) Ontology resolution Align bam - 62GB bam - 184GB bam -? text-17 Hipaa EHR - 17 Hipaa Safe-harbor de-ident Call Variants (vcf/gvcf) 497MB / 1.5GB bam -? NLP(text) SQL(EHR) Phenome extraction Totals (1E6 variants) / 1.5 Petabytes Combined: 1-3 Petabytes BAMs: 246 Petabytes Combined - 25 Terabytes text - 15MB EHR - 10MB Clinical data 7

8 The state of genomics! Illumina sequencers can sequence a genome for $1000! Aligners for producing binary alignment maps (BAMs) are increasingly accurate! A modern 1 PB storage rack holds up to whole-genome BAMs! Variant call format (VCF) files provide more compact representation than BAMs for storage and genome analysis 10 GB vs GB 8

9 Moving from genomes to genomes + phenotypes (G+P)! Genomic records track mutations! Phenotypic records track patient vital statistics and disease symptoms! Need both to find links between mutation and disease, or to screen for disease 9

10 The challenge of extracting G+P records! Different variant callers produce differing output from the same input BAMs Talwalkar et al: SMaSH toolkit for benchmarking variant caller accuracy! Variant caller algorithms still need improvement when identifying large structural variants: insertions/deletions, copy number variations, translocations Paten et al: Cactus graphs for variant representation! The VCF format is not well suited to representing structural variants Massie et al: ADAM genomic formats for cloud-scale genomic computing! Electronic health records (EMRs) are stored in inconsistent / incompatible schemas Natural language and medical billing code post-processing to extract EMRs 10

11 Getting consent to us G+P records! Institutional review boards / state and Federal laws require patient consent before commencing research / treatment using patient genomic records! HIPAA requires patient consent for release of protected health information 11

12 The challenges of getting consents! Incompatible consents hamper aggregating small corpuses into a large corpus Follow the principal investigator / clinician, not the patient Cover narrow use of genomic records / samples Vary by country, state, and institution! Lunshof et al: Open consent model in the Personal Genome Project 12

13 Protecting the privacy of G+P records! Genomes are not protected health information as yet, but will be soon! In general, de-identification of genomic data sufficient to keep it private 13

14 The challenges of protecting record privacy! Collecting a million genomes is a nationwide/worldwide effort, involving often contradictory privacy and consent laws from several jurisdictions! Combining genomic and phenotypic records is necessary to explore the genetic basis of disease, but inherently combines sensitive health information! De-identification is not foolproof Gymrek et al: Re-identified 1000 Genome Project donors by cross-referencing genomes with Y-chromosome and surname records at a social genealogy website! Common consensus holds that technological privacy solutions are fallible 14

15 Related work! Global Alliance: Exploring worldwide sharing of G+P records! Broad Institute (Harvard / MIT): Exploring the genetic causes of disease! UC Berkeley: Million cancer genome warehouse; genomic storage formats; genome pipeline processing algorithms! UC Santa Cruz: Applying computational / big data techniques to genomics! Illumina, Google, and other companies 15

16 Thank you! 16

17 References (clickable links)! Gymrek, M. et al., Identifying Personal Genomes by Surname Inference. Science 339(6117): , Jan 2013! Haussler, D. et al., A Million Cancer Genome Warehouse. UC Berkeley TR UCB/EECS , Nov 2012! Massie, M. et al., ADAM: Genomics Formats and Processing Patterns for Cloud Scale Computing. UC Berkeley TR UCB/EECS , Dec 2013! Paten, B. et al., Cactus graphs for genome comparisons. J Comput Biol. 18(3): Mar 2011! Talwalkar, A. et al., Smash: A benchmarking toolkit for variant calling, arxiv: [q-bio.gn],

Breast Cancer TAUG Overview and Implementation

Breast Cancer TAUG Overview and Implementation Breast Cancer TAUG Overview and Implementation Anita Umesh, Ph.D. Senior Scientist, Enterprise Informatics Illumina, Inc. Bay Area CDISC User Group 9 December 2015 2014 Illumina, Inc. All rights reserved.

More information

Somatic cancer applications of NGS in in vitro Diagnostics.

Somatic cancer applications of NGS in in vitro Diagnostics. Somatic cancer applications of NGS in in vitro Diagnostics. Nitin Udar PhD In Vitro Diagnsotics Division Illumina, Inc. 2013 Illumina, Inc. All rights reserved. Illumina, IlluminaDx, BaseSpace, BeadArray,

More information

Platform Approach to Cancer Discovery and Diagnostics Development

Platform Approach to Cancer Discovery and Diagnostics Development Platform Approach to Cancer Discovery and Diagnostics Development Joanne Yeakley Staff Manager, Scientific Research Diagnostic Assay Development 2009 Illumina, Inc. All rights reserved. Illumina, illuminadx,

More information

Molecular Characterization of Tumors Using Next-Generation Sequencing

Molecular Characterization of Tumors Using Next-Generation Sequencing Molecular Characterization of Tumors Using Next-Generation Sequencing Using BaseSpace to visualize molecular changes in cancer. Tumor-Normal Sequencing Data in BaseSpace To enable researchers new to next-generation

More information

P. Tang ( 鄧致剛 ); PJ Huang ( 黄栢榕 ) g( ); g ( ) Bioinformatics Center, Chang Gung University.

P. Tang ( 鄧致剛 ); PJ Huang ( 黄栢榕 ) g( ); g ( ) Bioinformatics Center, Chang Gung University. Databases and Tools for High Throughput Sequencing Analysis P. Tang ( 鄧致剛 ); PJ Huang ( 黄栢榕 ) g( ); g ( ) Bioinformatics Center, Chang Gung University. HTseq Platforms Applications on Biomedical Sciences

More information

Small RNA Sequencing. Project Workflow. Service Description. Sequencing Service Specification BGISEQ-500 SERVICE OVERVIEW SAMPLE PREPARATION

Small RNA Sequencing. Project Workflow. Service Description. Sequencing Service Specification BGISEQ-500 SERVICE OVERVIEW SAMPLE PREPARATION BGISEQ-500 SERVICE OVERVIEW Small RNA Sequencing Service Description Small RNAs are a type of non-coding RNA (ncrna) molecules that are less than 200nt in length. They are often involved in gene silencing

More information

Big Data Phenomics in the VA. Outline

Big Data Phenomics in the VA. Outline Big Phenomics in the VA Mary Whooley MD Director, VA Measurement Science QUERI San Francisco VA Health Care System University of California, San Francisco Kelly Cho PhD MPH Phenomics Lead, Million Veteran

More information

Characterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser

Characterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser Characterisation of structural variation in breast cancer genomes using paired-end sequencing on the Illumina Genome Analyser Phil Stephens Cancer Genome Project Why is it important to study cancer? Why

More information

Cancer Gene Panels. Dr. Andreas Scherer. Dr. Andreas Scherer President and CEO Golden Helix, Inc. Twitter: andreasscherer

Cancer Gene Panels. Dr. Andreas Scherer. Dr. Andreas Scherer President and CEO Golden Helix, Inc. Twitter: andreasscherer Cancer Gene Panels Dr. Andreas Scherer Dr. Andreas Scherer President and CEO Golden Helix, Inc. scherer@goldenhelix.com Twitter: andreasscherer About Golden Helix - Founded in 1998 - Main outside investor:

More information

How Big Data and Advanced Analytics Can Improve Population Health: Now and In the Near Future

How Big Data and Advanced Analytics Can Improve Population Health: Now and In the Near Future How Big Data and Advanced Analytics Can Improve Population Health: Now and In the Near Future William J. Kassler, MD, MPH Deputy Chief Health Officer Lead Population Health Officer Precision Medicine Completion

More information

Moving Family Health History & Genetic Test Result Data into the Electronic Health Record for Clinical Decision Support

Moving Family Health History & Genetic Test Result Data into the Electronic Health Record for Clinical Decision Support Moving Family Health History & Genetic Test Result Data into the Electronic Health Record for Clinical Decision Support HL7 30 Years of Standards Development HIMSS February 21, 2017 Grant M. Wood Intermountain

More information

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits Next-generation performance in liquid biopsies 2 Accelerating clinical research From liquid biopsy to next-generation

More information

Personalized, Evidence-based, Outcome-driven Healthcare Empowered by IBM Cognitive Computing Technologies. Guotong Xie IBM Research - China

Personalized, Evidence-based, Outcome-driven Healthcare Empowered by IBM Cognitive Computing Technologies. Guotong Xie IBM Research - China Personalized, Evidence-based, Outcome-driven Healthcare Empowered by IBM Cognitive Computing Technologies Guotong Xie IBM Research - China Explosion of Healthcare Data Exogenous data 1,100 Terabytes Generated

More information

DNA-seq Bioinformatics Analysis: Copy Number Variation

DNA-seq Bioinformatics Analysis: Copy Number Variation DNA-seq Bioinformatics Analysis: Copy Number Variation Elodie Girard elodie.girard@curie.fr U900 institut Curie, INSERM, Mines ParisTech, PSL Research University Paris, France NGS Applications 5C HiC DNA-seq

More information

NAVIFY Tumor Board NAVIFY

NAVIFY Tumor Board NAVIFY NAVIFY Tumor Board Make the most informed personalized treatment decisions possible by leveraging innovative technologies and the latest scientific and clinical data WHAT S INSIDE Key Takeaways NAVIFY

More information

Nature Methods: doi: /nmeth.3115

Nature Methods: doi: /nmeth.3115 Supplementary Figure 1 Analysis of DNA methylation in a cancer cohort based on Infinium 450K data. RnBeads was used to rediscover a clinically distinct subgroup of glioblastoma patients characterized by

More information

Breast and ovarian cancer in Serbia: the importance of mutation detection in hereditary predisposition genes using NGS

Breast and ovarian cancer in Serbia: the importance of mutation detection in hereditary predisposition genes using NGS Breast and ovarian cancer in Serbia: the importance of mutation detection in hereditary predisposition genes using NGS dr sc. Ana Krivokuća Laboratory for molecular genetics Institute for Oncology and

More information

PERSONALIZED GENETIC REPORT CLIENT-REPORTED DATA PURPOSE OF THE X-SCREEN TEST

PERSONALIZED GENETIC REPORT CLIENT-REPORTED DATA PURPOSE OF THE X-SCREEN TEST INCLUDED IN THIS REPORT: REVIEW OF YOUR GENETIC INFORMATION RELEVANT TO ENDOMETRIOSIS PERSONAL EDUCATIONAL INFORMATION RELEVANT TO YOUR GENES INFORMATION FOR OBTAINING YOUR ENTIRE X-SCREEN DATA FILE PERSONALIZED

More information

Advance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library

Advance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library Advance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library Marilou Wijdicks International Product Manager Research For Life Science Research Only. Not for Use in Diagnostic Procedures.

More information

A Unique Partnership to Advance Alzheimer's Research through Whole Genome Sequencing.

A Unique Partnership to Advance Alzheimer's Research through Whole Genome Sequencing. A Unique Partnership to Advance Alzheimer's Research through Whole Genome Sequencing. Dean Hartley, Ph.D., Alzheimer's Association, Emily Drabant, Ph.D., 23 and me, Anne Wojcicki, 23 and me, Rob Fetherstonhaugh,

More information

Golden Helix s End-to-End Solution for Clinical Labs

Golden Helix s End-to-End Solution for Clinical Labs Golden Helix s End-to-End Solution for Clinical Labs Steven Hystad - Field Application Scientist Nathan Fortier Senior Software Engineer 20 most promising Biotech Technology Providers Top 10 Analytics

More information

Introduction to the Partners Biobank Portal. December 2016

Introduction to the Partners Biobank Portal. December 2016 Introduction to the Partners Biobank Portal December 2016 Agenda About the Partners Biobank About the Biobank Portal Data Types in the Biobank Sample types DNA. Plasma and Serum Consent Genomic Data Health

More information

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits Accelerating clinical research Next-generation sequencing (NGS) has the ability to interrogate many different genes and detect

More information

Data Sharing Consortiums and Large Datasets to Inform Cancer Diagnosis

Data Sharing Consortiums and Large Datasets to Inform Cancer Diagnosis February, 13th 2018 Data Sharing Consortiums and Large Datasets to Inform Cancer Diagnosis Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging and Pathology Expertise and Technologies:

More information

Protecting Patient Privacy in Genomic Analysis

Protecting Patient Privacy in Genomic Analysis Protecting Patient Privacy in Genomic Analysis David Wu Stanford University based on joint works with: Gill Bejerano, Bonnie Berger, Johannes A. Birgmeier, Dan Boneh, Hyunghoon Cho, and Karthik A. Jagadeesh

More information

DNA Sequence Bioinformatics Analysis with the Galaxy Platform

DNA Sequence Bioinformatics Analysis with the Galaxy Platform DNA Sequence Bioinformatics Analysis with the Galaxy Platform University of São Paulo, Brazil 28 July - 1 August 2014 Dave Clements Johns Hopkins University Robson Francisco de Souza University of São

More information

A Predictive Chronological Model of Multiple Clinical Observations T R A V I S G O O D W I N A N D S A N D A M. H A R A B A G I U

A Predictive Chronological Model of Multiple Clinical Observations T R A V I S G O O D W I N A N D S A N D A M. H A R A B A G I U A Predictive Chronological Model of Multiple Clinical Observations T R A V I S G O O D W I N A N D S A N D A M. H A R A B A G I U T H E U N I V E R S I T Y O F T E X A S A T D A L L A S H U M A N L A N

More information

Multi-modal Patient Cohort Identification from EEG Report and Signal Data

Multi-modal Patient Cohort Identification from EEG Report and Signal Data Multi-modal Patient Cohort Identification from EEG Report and Signal Data Travis R. Goodwin and Sanda M. Harabagiu The University of Texas at Dallas Human Language Technology Research Institute http://www.hlt.utdallas.edu

More information

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University Role of Chemical lexposure in Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University CNV Discovery Reference Genetic

More information

Using the NIH Collaboratory's and PCORnet's distributed data networks for clinical trials and observational research - A preview

Using the NIH Collaboratory's and PCORnet's distributed data networks for clinical trials and observational research - A preview Using the NIH Collaboratory's and PCORnet's distributed data networks for clinical trials and observational research - A preview Millions of people. Strong collaborations. Privacy first. Jeffrey Brown,

More information

Clinical Review Report (Sample)

Clinical Review Report (Sample) CADTH COMMON DRUG REVIEW Clinical Review Report (Sample) GENERIC DRUG NAME (BRAND NAME) (Manufacturer) Indication: Text Disclaimer: The information in this document is intended to help Canadian health

More information

Whole Genome and Transcriptome Analysis of Anaplastic Meningioma. Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute

Whole Genome and Transcriptome Analysis of Anaplastic Meningioma. Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute Whole Genome and Transcriptome Analysis of Anaplastic Meningioma Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute Outline Anaplastic meningioma compared to other cancers Whole genomes

More information

Protecting Patient Privacy in Genomic Analysis

Protecting Patient Privacy in Genomic Analysis Protecting Patient Privacy in Genomic Analysis David Wu Stanford University based on joint works with: Gill Bejerano, Bonnie Berger, Johannes A. Birgmeier, Dan Boneh, Hyunghoon Cho, and Karthik A. Jagadeesh

More information

Watson Summit Prague 2017

Watson Summit Prague 2017 Watson for Oncology Matěj Adam Watson Health Executive May 2017 Watson Summit Prague 2017 an IBM Company Leadership & 23 Years Patent Leadership Research Spend Global Presence Technology 7300+ 2015 $6B

More information

Identifying Mutations Responsible for Rare Disorders Using New Technologies

Identifying Mutations Responsible for Rare Disorders Using New Technologies Identifying Mutations Responsible for Rare Disorders Using New Technologies Jacek Majewski, Department of Human Genetics, McGill University, Montreal, QC Canada Mendelian Diseases Clear mode of inheritance

More information

The National Vaccine Advisory Committee: Reducing Patient and Provider Barriers to Maternal Immunizations

The National Vaccine Advisory Committee: Reducing Patient and Provider Barriers to Maternal Immunizations The National Vaccine Advisory Committee: Reducing Patient and Provider Barriers to Maternal Immunizations Executive Summary Maternal immunization provides important health benefits for pregnant women and

More information

GENE EXPRESSION PROFILING AND PROTEIN BIOMARKERS FOR PROSTATE CANCER MANAGEMENT

GENE EXPRESSION PROFILING AND PROTEIN BIOMARKERS FOR PROSTATE CANCER MANAGEMENT CANCER MANAGEMENT Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs

More information

Studying Alternative Splicing

Studying Alternative Splicing Studying Alternative Splicing Meelis Kull PhD student in the University of Tartu supervisor: Jaak Vilo CS Theory Days Rõuge 27 Overview Alternative splicing Its biological function Studying splicing Technology

More information

Case Studies and Informed Consent. Ashley Cannon, PhD, MS, CGC Genomics Immersion Course 10/14/2015

Case Studies and Informed Consent. Ashley Cannon, PhD, MS, CGC Genomics Immersion Course 10/14/2015 Case Studies and Informed Consent Ashley Cannon, PhD, MS, CGC Genomics Immersion Course 10/14/2015 Case Study 1 You are studying the gene mutations in the NF1 gene in the hope of establishing genotype-phenotype

More information

Integrated Analysis of Copy Number and Gene Expression

Integrated Analysis of Copy Number and Gene Expression Integrated Analysis of Copy Number and Gene Expression Nexus Copy Number provides user-friendly interface and functionalities to integrate copy number analysis with gene expression results for the purpose

More information

PRECISION INSIGHTS. GPS Cancer. Molecular Insights You Can Rely On. Tumor-normal sequencing of DNA + RNA expression.

PRECISION INSIGHTS. GPS Cancer. Molecular Insights You Can Rely On. Tumor-normal sequencing of DNA + RNA expression. PRECISION INSIGHTS GPS Cancer Molecular Insights You Can Rely On Tumor-normal sequencing of DNA + RNA expression www.nanthealth.com Cancer Care is Evolving Oncologists use all the information available

More information

Not all NLP is Created Equal:

Not all NLP is Created Equal: Not all NLP is Created Equal: CAC Technology Underpinnings that Drive Accuracy, Experience and Overall Revenue Performance Page 1 Performance Perspectives Health care financial leaders and health information

More information

Introduction to Systems Biology of Cancer Lecture 2

Introduction to Systems Biology of Cancer Lecture 2 Introduction to Systems Biology of Cancer Lecture 2 Gustavo Stolovitzky IBM Research Icahn School of Medicine at Mt Sinai DREAM Challenges High throughput measurements: The age of omics Systems Biology

More information

Genome. Institute. GenomeVIP: A Genomics Analysis Pipeline for Cloud Computing with Germline and Somatic Calling on Amazon s Cloud. R. Jay Mashl.

Genome. Institute. GenomeVIP: A Genomics Analysis Pipeline for Cloud Computing with Germline and Somatic Calling on Amazon s Cloud. R. Jay Mashl. GenomeVIP: the Genome Institute at Washington University A Genomics Analysis Pipeline for Cloud Computing with Germline and Somatic Calling on Amazon s Cloud R. Jay Mashl October 20, 2014 Turnkey Variant

More information

Deep Learning Analytics for Predicting Prognosis of Acute Myeloid Leukemia with Cytogenetics, Age, and Mutations

Deep Learning Analytics for Predicting Prognosis of Acute Myeloid Leukemia with Cytogenetics, Age, and Mutations Deep Learning Analytics for Predicting Prognosis of Acute Myeloid Leukemia with Cytogenetics, Age, and Mutations Andy Nguyen, M.D., M.S. Medical Director, Hematopathology, Hematology and Coagulation Laboratory,

More information

A Programming Approach to the CS Principles Data Task

A Programming Approach to the CS Principles Data Task A Programming Approach to the CS Principles Data Task (from The Beauty and Joy of Computing team) UC Berkeley Sr Lecturer SOE Dan Garcia bjc.berkeley.edu Broadening Participation in HS CS! New Course:

More information

Computational Analysis of UHT Sequences Histone modifications, CAGE, RNA-Seq

Computational Analysis of UHT Sequences Histone modifications, CAGE, RNA-Seq Computational Analysis of UHT Sequences Histone modifications, CAGE, RNA-Seq Philipp Bucher Wednesday January 21, 2009 SIB graduate school course EPFL, Lausanne ChIP-seq against histone variants: Biological

More information

Factor 3: The practice measures or receives data on at least three chronic or acute care clinical measures

Factor 3: The practice measures or receives data on at least three chronic or acute care clinical measures Factor 3: The practice measures or receives data on at least three chronic or acute care clinical measures The Clinical Quality Measures report within PCC EHR calculates your clinician and/or practice-wide

More information

Cancer Genomics Testing: diagnostic yield and reimbursement

Cancer Genomics Testing: diagnostic yield and reimbursement Cancer Genomics Testing: diagnostic yield and reimbursement Anthony N. Sireci, MD, MS Assistant Professor of Pathology and Cell Biology Columbia University Medical Center Assistant Director and Physician

More information

Supplementary Figure 1

Supplementary Figure 1 Supplementary Figure 1 An example of the gene-term-disease network automatically generated by Phenolyzer web server for 'autism'. The largest word represents the user s input term, Autism. The pink round

More information

Overview: TB Alliance Drug Development Pipeline

Overview: TB Alliance Drug Development Pipeline Overview: TB Alliance Drug Development Pipeline Mengchun Li, MD Head of Pharmacovigilance, TB Alliance Mar 26, 2018 TB Alliance is a not for profit organization dedicated to the discovery and development

More information

Simple, rapid, and reliable RNA sequencing

Simple, rapid, and reliable RNA sequencing Simple, rapid, and reliable RNA sequencing RNA sequencing applications RNA sequencing provides fundamental insights into how genomes are organized and regulated, giving us valuable information about the

More information

Large-scale identity-by-descent mapping discovers rare haplotypes of large effect. Suyash Shringarpure 23andMe, Inc. ASHG 2017

Large-scale identity-by-descent mapping discovers rare haplotypes of large effect. Suyash Shringarpure 23andMe, Inc. ASHG 2017 Large-scale identity-by-descent mapping discovers rare haplotypes of large effect Suyash Shringarpure 23andMe, Inc. ASHG 2017 1 Why care about rare variants of large effect? Months from randomization 2

More information

The Deciphering Development Disorders (DDD) project: What a genomic approach can achieve

The Deciphering Development Disorders (DDD) project: What a genomic approach can achieve The Deciphering Development Disorders (DDD) project: What a genomic approach can achieve RCP ADVANCED MEDICINE, LONDON FEB 5 TH 2018 HELEN FIRTH DM FRCP DCH, SANGER INSTITUTE 3,000,000,000 bases in each

More information

Georgia Cancer Quality Information Exchange

Georgia Cancer Quality Information Exchange Georgia Cancer Quality Information Exchange Measuring Progress, Motivating Change William J. Todd President & Chief Executive Officer October 5, 2009 Hamilton Jordan 1944 2008 Georgia Cancer Coalition

More information

Jackson Distinguished Professor of Clinical Medicine, Harvard Medical School

Jackson Distinguished Professor of Clinical Medicine, Harvard Medical School Dennis Ausiello, M.D. Founder and Director, Center for Assessment Technology and Continuous Health (CATCH) Physician-in-Chief Emeritus, MGH Jackson Distinguished Professor of Clinical Medicine, Harvard

More information

The Foundations of Personalized Medicine

The Foundations of Personalized Medicine The Foundations of Personalized Medicine Jeremy M. Berg Pittsburgh Foundation Professor and Director, Institute for Personalized Medicine University of Pittsburgh Personalized Medicine Physicians have

More information

QIAsymphony DSP Circulating DNA Kit

QIAsymphony DSP Circulating DNA Kit QIAsymphony DSP Circulating DNA Kit February 2017 Performance Characteristics 937556 Sample to Insight Contents Performance Characteristics... 4 Basic performance... 4 Run precision... 6 Equivalent performance

More information

Human Genetics 542 Winter 2018 Syllabus

Human Genetics 542 Winter 2018 Syllabus Human Genetics 542 Winter 2018 Syllabus Monday, Wednesday, and Friday 9 10 a.m. 5915 Buhl Course Director: Tony Antonellis Jan 3 rd Wed Mapping disease genes I: inheritance patterns and linkage analysis

More information

Overcoming challenges in DNA sample collection

Overcoming challenges in DNA sample collection Overcoming challenges in DNA sample collection How epidemiological researchers are maximizing compliance rates with non-invasive DNA self-collection (outside the USA) (in the USA) Some DNA Genotek products

More information

Hospital Biobanks - Use of Specimens and Clinical Information in Disease Phenotyping

Hospital Biobanks - Use of Specimens and Clinical Information in Disease Phenotyping Hospital Biobanks - Use of Specimens and Clinical Information in Disease Phenotyping Olli Carpén Auria Biobank, University of Turku and Turku University Hospital ocarpen@utu.fi Understanding of disease

More information

Impressions of a New NCI Director: Big Data

Impressions of a New NCI Director: Big Data Impressions of a New NCI Director: Big Data Norman E. Sharpless, M.D. Cancer Informatics for Cancer Centers April 3, 2018 www.cancer.gov www.cancer.gov/espanol October 17, 2018 NCI: Leading the National

More information

Request for Applications Post-Traumatic Stress Disorder GWAS

Request for Applications Post-Traumatic Stress Disorder GWAS Request for Applications Post-Traumatic Stress Disorder GWAS PROGRAM OVERVIEW Cohen Veterans Bioscience & The Stanley Center for Psychiatric Research at the Broad Institute Collaboration are supporting

More information

ONE MONITORING SOLUTION TO MEASURE MORE. Zephyr Performance Systems for academics and researchers

ONE MONITORING SOLUTION TO MEASURE MORE. Zephyr Performance Systems for academics and researchers ONE MONITORING SOLUTION TO MEASURE MORE Zephyr Performance Systems for academics and researchers GettyImages-530750346.jpg Vital signs and accelerometry. Tracking both is integral to your research. But

More information

Human Genetics 542 Winter 2017 Syllabus

Human Genetics 542 Winter 2017 Syllabus Human Genetics 542 Winter 2017 Syllabus Monday, Wednesday, and Friday 9 10 a.m. 5915 Buhl Course Director: Tony Antonellis Module I: Mapping and characterizing simple genetic diseases Jan 4 th Wed Mapping

More information

SCALPEL MICRO-ASSEMBLY APPROACH TO DETECT INDELS WITHIN EXOME-CAPTURE DATA. Giuseppe Narzisi, PhD Schatz Lab

SCALPEL MICRO-ASSEMBLY APPROACH TO DETECT INDELS WITHIN EXOME-CAPTURE DATA. Giuseppe Narzisi, PhD Schatz Lab SCALPEL MICRO-ASSEMBLY APPROACH TO DETECT INDELS WITHIN EXOME-CAPTURE DATA Giuseppe Narzisi, PhD Schatz Lab November 14, 2013 Micro-Assembly Approach to detect INDELs 2 Outline Scalpel micro-assembly pipeline

More information

THE UC SANTA CRUZ GENOMICS INSTITUTE. David Haussler Distinguished Professor, Biomolecular Engineering Scientific Director

THE UC SANTA CRUZ GENOMICS INSTITUTE. David Haussler Distinguished Professor, Biomolecular Engineering Scientific Director THE UC SANTA CRUZ GENOMICS INSTITUTE David Haussler Distinguished Professor, Biomolecular Engineering Scientific Director April 8, 2015 OUR MISSION Unlocking the world s genomic data to accelerate medical

More information

Grand Challenge and other funding opportunities at Cancer Research UK. Jamie Meredith, 9 th Dec 15

Grand Challenge and other funding opportunities at Cancer Research UK. Jamie Meredith, 9 th Dec 15 Grand Challenge and other funding opportunities at Cancer Research UK Jamie Meredith, 9 th Dec 15 Multidisciplinary research at CRUK OVERVIEW About CRUK CRUKs research strategy A focus on multidisciplinary

More information

Trinity: Transcriptome Assembly for Genetic and Functional Analysis of Cancer [U24]

Trinity: Transcriptome Assembly for Genetic and Functional Analysis of Cancer [U24] Trinity: Transcriptome Assembly for Genetic and Functional Analysis of Cancer [U24] ITCR meeting, June 2016 The Cancer Transcriptome A window into the (expressed) genetic and epigenetic state of a tumor

More information

GENETIC TESTING FOR PREDICTING RISK OF NONFAMILIAL BREAST CANCER

GENETIC TESTING FOR PREDICTING RISK OF NONFAMILIAL BREAST CANCER Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent upon

More information

38 Int'l Conf. Bioinformatics and Computational Biology BIOCOMP'16

38 Int'l Conf. Bioinformatics and Computational Biology BIOCOMP'16 38 Int'l Conf. Bioinformatics and Computational Biology BIOCOMP'16 PGAR: ASD Candidate Gene Prioritization System Using Expression Patterns Steven Cogill and Liangjiang Wang Department of Genetics and

More information

ACE ImmunoID Biomarker Discovery Solutions ACE ImmunoID Platform for Tumor Immunogenomics

ACE ImmunoID Biomarker Discovery Solutions ACE ImmunoID Platform for Tumor Immunogenomics ACE ImmunoID Biomarker Discovery Solutions ACE ImmunoID Platform for Tumor Immunogenomics Precision Genomics for Immuno-Oncology Personalis, Inc. ACE ImmunoID When one biomarker doesn t tell the whole

More information

Memory-Augmented Active Deep Learning for Identifying Relations Between Distant Medical Concepts in Electroencephalography Reports

Memory-Augmented Active Deep Learning for Identifying Relations Between Distant Medical Concepts in Electroencephalography Reports Memory-Augmented Active Deep Learning for Identifying Relations Between Distant Medical Concepts in Electroencephalography Reports Ramon Maldonado, BS, Travis Goodwin, PhD Sanda M. Harabagiu, PhD The University

More information

Breast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data

Breast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data Breast cancer Inferring Transcriptional Module from Breast Cancer Profile Data Breast Cancer and Targeted Therapy Microarray Profile Data Inferring Transcriptional Module Methods CSC 177 Data Warehousing

More information

Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNA

Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNA www.impactjournals.com/oncotarget/ Oncotarget, Supplementary Materials 2016 Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) DNA Supplementary Materials

More information

About this consent form. Why is this research study being done? Partners HealthCare System Research Consent Form

About this consent form. Why is this research study being done? Partners HealthCare System Research Consent Form Protocol Title: Gene Sequence Variants in Fibroid Biology Principal Investigator: Cynthia C. Morton, Ph.D. Site Principal Investigator: Cynthia C. Morton, Ph.D. Description of About this consent form Please

More information

GENEPLANET. The value proposition of genetic testing as an insurance offering

GENEPLANET. The value proposition of genetic testing as an insurance offering GENEPLANET The value proposition of genetic testing as an insurance offering ABOUT GENEPLANET More than 10 YEARS on the market. More than 20 NATIONALITIES, over 50 employees. Present in more than 30 COUNTRIES

More information

Theravance Announces Positive Results from Phase 1 and Phase 2 Clinical Studies with TD-1211 in Development for Opioid-Induced Constipation

Theravance Announces Positive Results from Phase 1 and Phase 2 Clinical Studies with TD-1211 in Development for Opioid-Induced Constipation Theravance Announces Positive Results from Phase 1 and Phase 2 Clinical Studies with TD-1211 in Development for Opioid-Induced Constipation TD-1211 Achieves Primary and Secondary Endpoints SOUTH SAN FRANCISCO,

More information

Illumina s Cancer Research Portfolio and Dedicated Workflows

Illumina s Cancer Research Portfolio and Dedicated Workflows Illumina s Cancer Research Portfolio and Dedicated Workflows Michael Sohn Clinical Sales Specialist Spain&Italy 2017 2017 Illumina, Inc. All rights reserved. Illumina, 24sure, BaseSpace, BeadArray, BlueFish,

More information

Andrew Parrish, Richard Caswell, Garan Jones, Christopher M. Watson, Laura A. Crinnion 3,4, Sian Ellard 1,2

Andrew Parrish, Richard Caswell, Garan Jones, Christopher M. Watson, Laura A. Crinnion 3,4, Sian Ellard 1,2 METHOD ARTICLE An enhanced method for targeted next generation sequencing copy number variant detection using ExomeDepth [version 1; referees: 1 approved, 1 approved with reservations] 1 2 1 3,4 Andrew

More information

FIELD NOTES. Chris Anderson our Senior Editor gives a roundup of the recent developments in the precision medicine field.

FIELD NOTES. Chris Anderson our Senior Editor gives a roundup of the recent developments in the precision medicine field. FIELD NOTES Chris Anderson our Senior Editor gives a roundup of the recent developments in the precision medicine field. QIAGEN on behalf of the Allele Frequency community Adding value to allele data REDWOOD

More information

Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology

Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology 9650 Rockville Pike, Bethesda, Maryland 20814 Tel: 301-634-7939 Fax: 301-634-7990 Email:

More information

NGS in Cancer Pathology After the Microscope: From Nucleic Acid to Interpretation

NGS in Cancer Pathology After the Microscope: From Nucleic Acid to Interpretation NGS in Cancer Pathology After the Microscope: From Nucleic Acid to Interpretation Michael R. Rossi, PhD, FACMG Assistant Professor Division of Cancer Biology, Department of Radiation Oncology Department

More information

National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2011 Formula Grant

National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2011 Formula Grant National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2011 Formula Grant Reporting Period July 1, 2012 June 30, 2013 Formula Grant Overview The NSABP Foundation

More information

Medical Context Descriptors

Medical Context Descriptors R H Baud, L E Cousineau, S Roessingh* Knowledge Discovery Project Cousineau Consulting LLC 2806 Fennel Rd, Edgewater MD 21037 E-mail: steve.roessingh@gmail.com *Corresponding author Abstract: The study

More information

GENETIC TESTING WITH MOLECULAR PANEL TESTING OF CANCERS TO IDENTIFY TARGETED THERAPIES

GENETIC TESTING WITH MOLECULAR PANEL TESTING OF CANCERS TO IDENTIFY TARGETED THERAPIES IDENTIFY TARGETED THERAPIES Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices

More information

Chapter 1 : Genetics 101

Chapter 1 : Genetics 101 Chapter 1 : Genetics 101 Understanding the underlying concepts of human genetics and the role of genes, behavior, and the environment will be important to appropriately collecting and applying genetic

More information

Clinical Policy: Electric Tumor Treating Fields (Optune) Reference Number: CP.MP.145

Clinical Policy: Electric Tumor Treating Fields (Optune) Reference Number: CP.MP.145 Clinical Policy: Electric Tumor Treating Fields (Optune) Reference Number: CP.MP.145 Effective Date: 05/17 Last Review Date: 06/17 See Important Reminder at the end of this policy for important regulatory

More information

We see health care. differently. Comprehensive data Novel insights Transformative actions Lasting value

We see health care. differently. Comprehensive data Novel insights Transformative actions Lasting value We see health care differently Comprehensive data Novel insights Transformative actions Lasting value 24 Hours of Optum data: Creating a more complete health picture We capture: Largest EHR dataset 90

More information

THE OPTICAL SOCIETY ONLINE JOURNALS SINGLE SITE LICENSE AGREEMENT

THE OPTICAL SOCIETY ONLINE JOURNALS SINGLE SITE LICENSE AGREEMENT THE OPTICAL SOCIETY ONLINE JOURNALS SINGLE SITE LICENSE AGREEMENT BY THIS AGREEMENT between The Optical Society ( OSA ) and the named below ( Licensee ), OSA grants to Licensee access to the OSA online

More information

Media Contact: Ron Rogers Investor Contact: Scott Gleason (801) (801)

Media Contact: Ron Rogers Investor Contact: Scott Gleason (801) (801) News Release Media Contact: Ron Rogers Investor Contact: Scott Gleason (801) 584-3065 (801) 584-1143 rrogers@myriad.com sgleason@myriad.com Myriad Receives FDA Approval of BRACAnalysis CDx as Companion

More information

Application of AI in Healthcare. Alistair Erskine MD MBA Chief Informatics Officer

Application of AI in Healthcare. Alistair Erskine MD MBA Chief Informatics Officer Application of AI in Healthcare Alistair Erskine MD MBA Chief Informatics Officer 1 Overview Why AI in Healthcare topic matters Is AI just another shiny objects? Geisinger AI collaborations Categories

More information

Genetic causes 90% Other causes 10% No variants are found in known genes associated with ADPKD

Genetic causes 90% Other causes 10% No variants are found in known genes associated with ADPKD CLINICIAN PRODUCT SHEET Genome.One Polycystic Kidney Disease Test Genome.One offers a diagnostic genetic test for patients with polycystic kidney disease (PKD), with a focus on the most common form, autosomal

More information

Research Consent Form Newton-Wellesley Hospital 2014 Washington Street Newton, MA 02462

Research Consent Form Newton-Wellesley Hospital 2014 Washington Street Newton, MA 02462 Protocol Title: Principal Investigator: Description of Subject Population: Protocol Version: Consent Form Revision Date: ABOUT THIS CONSENT FORM STUDY CONTACTS

More information

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Ordering Information Acceptable specimen types: Fresh blood sample (3-6 ml EDTA; no time limitations associated with receipt)

More information

Detecting and monitoring foodborne illness outbreaks: Twitter communications and the 2015 U.S. Salmonella outbreak linked to imported cucumbers

Detecting and monitoring foodborne illness outbreaks: Twitter communications and the 2015 U.S. Salmonella outbreak linked to imported cucumbers Detecting and monitoring foodborne illness outbreaks: Twitter communications and the 2015 U.S. Salmonella outbreak linked to imported cucumbers Abstract This research uses Twitter, as a social media device,

More information

Building Cognitive Computing for Healthcare

Building Cognitive Computing for Healthcare Building Cognitive Computing for Healthcare Boston University Digital Health Initiative Round Table February 27 th 2017 Patrick McNeillie M.D. Clinical Lead and Senior Architect on Watson for Genomics

More information

Identifying the Zygosity Status of Twins Using Bayes Network and Estimation- Maximization Methodology

Identifying the Zygosity Status of Twins Using Bayes Network and Estimation- Maximization Methodology Identifying the Zygosity Status of Twins Using Bayes Network and Estimation- Maximization Methodology Yicun Ni (ID#: 9064804041), Jin Ruan (ID#: 9070059457), Ying Zhang (ID#: 9070063723) Abstract As the

More information

Illuminating the genetics of complex human diseases

Illuminating the genetics of complex human diseases Illuminating the genetics of complex human diseases Michael Schatz Sept 27, 2012 Beyond the Genome @mike_schatz / #BTG2012 Outline 1. De novo mutations in human diseases 1. Autism Spectrum Disorder 2.

More information

Family History & Early Onset Colorectal Cancer Task Group

Family History & Early Onset Colorectal Cancer Task Group Family History & Early Onset Colorectal Cancer Task Group Pre-Annual Meeting Task Group Informational Webinar 2018 Updates / 2019 Planning October 17, 2018 2:00 p.m. EST Agenda -Welcome & Introductions

More information